Navigation Links
Symphony PCS

ProductsSymphony PCS
Company DePuy Orthopaedics, Inc.
Item Symphony PCS
Features Low blood volume. The Symphony II PCS can produce consistently high levels of platelet concentrate from as little as 55-110 ml of the patient's blood. Permits multiple runs on a single patient, if necessary. Automated system captures platelets available in whole blood, assuring a consistently high level of platelet concentrate. Consistently yields three to six times the baseline level of platelets. Growth factors found in platelets - PDGF, TGF-, EGF, and VEGF - are also increased three to six times. Quick, automated system makes platelet concentrate available in less than 15 minutes, eliminating intraoperative delays.
Description Symphony Platelet Concentrate System is a point-of-care system designed for the rapid preparation of Platelet Concentrate (also referred to as Platelet Rich Plasma - PRP) and Platelet Poor Plasma (PPP) from a small sample of blood. The Symphony PCS concentrates the body's natural growth factors, which are found in the platelets. The platelet concentrate can be mixed with autograft and allograft bone grafting materials prior to application to an orthopedic surgical site as deemed necessary by the clinical use requirements. The Symphony PCS produces autologous platelet concentrate containing viable platelets with a full compliment of associated growth factors.
Info DePuy Orthopaedics, Inc.
Customer Service: (800) 366-8143
Web site: http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b9880772d01

Related medicine products :

1. Symphony I/C Graft Chambers
2. Symphony II
3. Symphony SR 2250
4. Symphony DR 2550
5. TCS Symphony
6. MAGNETOM Symphony
...fiers (HCH) capture the patient`s exhaled heat and...ll and compact, they are specially treated to prov...ding on the tidal volume requirements, select eith...CH is ideal for patient tidal volumes of 150 to 15...
...fiers (HCH) capture the patient`s exhaled heat and...ll and compact, they are specially treated to prov...ding on the tidal volume requirements, select eith...CH is ideal for patient tidal volumes of 150 to 15...
HME only
Indications For Usage: ,Infant (recommended tidal volume 20-70ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended
Medicine Products:
(Date:7/25/2008)...wswire/ -- Sagent Pharmaceuticals, Inc.,a private...nounced that it,has launched amiodarone HCl inject... the treatment and prophylaxis of frequently recur...unstable ventricular,tachycardia -- a potentially ...iodarone HCl injection will be available immediate...
(Date:7/25/2008)...gus can cause immune system changes , , ...ence linking gastroesophageal reflux disease (GERD...y Medical Center researchers. , An association ...1970s, and since then studies have shown that betw...lso experience GERD symptoms. But the actual link ...
(Date:7/25/2008)...ou are an Olympian, Professional Athlete, Elite Am...u Need to Know about Hydration to Boost Sports Per...r , Marina del Rey, Calif...tes are heading to Beijing following years of inte...pes of capturing an Olympic medal and securing the...
(Date:7/24/2008)...ers at Wake Forest University Baptist Medical Cent...that the hepatitis C virus slows or stunts the imm...atients are treated with a combination of drugs kn...ction is more serious in HIV-infected people, lead...s for Disease Control. Intravenous drug use is a m...
Breaking Medicine News(10 mins):Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3
...le havoc, visible by the huge numbers of homes raz...victims’ lives.// The intangible consequences, not...ar deeper, is the state of mind of the survivors, ...sulting in many forms of mental ailments - a study...
...nd doctors were stranded for days at the Charity H...eans.// On the 1-year anniversary of the storm, Ch...u look around at where I'm standing, you might thi...d of abandoned building, but, actually, this is a ...
...has shown that the fog of alcoholism can clear up ...e September issue of Alcoholism: Clinical & Experi...des the direct effect of booze the brain of alcoho...sychological deficits continue even after an alcoh...
...d after a lengthy surgery. 3 weeks later, they hav...father, it is an indication of their recovery. Ken... They were conjoined at the trunk and shared sever... and 2 legs. Due to the various medical complicati...
Other Medicine News:Health News:Long term Sobriety can Reverse Effects of Alcohol Damage 2Health News:Conjoined twins doing well after separation 2
(Date:7/23/2008)... July 23 /- Dendreon Corpor...ects the Independent Data,Monitoring Committee (ID...,of overall survival relating to the Company,s Pha...noma Treatment, also known as D9902B) clinical tri...Company,s investigational,active cellular immunoth...
(Date:7/22/2008)...LIS, July 22 /- Nonin Medical, a lead...s for more than 20 years, has entered,the clinical... measure,regional oxygen saturation. Today,s most ...inuous monitoring of the regional blood oxygenatio...ng data and outcomes from an ongoing clinical stud...
(Date:7/22/2008)...the-Art PET Study Confirms Tyrima Exhibits Excelle...es - - Results Support Initiation of Phase I..., July 22 /- CeNeRx BioPharma,Inc., ...izing innovative,treatments for diseases of the ce...ance its lead candidate Tyrima(TM) into Phase II t...
(Date:7/22/2008)...ic treatment with chemotherapy and pegylated enzym...ared to chemotherapy alone - - Pe...22 /- Halozyme Therapeutics...ny developing and,commercializing products targeti...resentation of positive pre-clinical animal effica...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Global Sound Conference Brings Worlds Top Sound Researchers Technologists and Musicians to Los Angeles for Four Day Symposium 14733 1Global Sound Conference Brings Worlds Top Sound Researchers Technologists and Musicians to Los Angeles for Four Day Symposium 14733 2Global Sound Conference Brings Worlds Top Sound Researchers Technologists and Musicians to Los Angeles for Four Day Symposium 14733 3FDA Identifies Contaminant in Blood Thinning Drug 14731 1FDA Identifies Contaminant in Blood Thinning Drug 14731 2FDA Identifies Contaminant in Blood Thinning Drug 14731 3PRA International Announces New Office Opening in Mumbai 14728 1PRA International Announces New Office Opening in Mumbai 14728 2Food insecurity linked with HIV AIDS in Africa 14725 1Food insecurity linked with HIV AIDS in Africa 14725 2
...7 - Arrowhead,Research Corporation (NASDAQ:ARWR) a...ndo Pharmaceuticals has published,results in the P...AS) of the first non-human primate study to use mu...therapeutic candidate., Calando is using its propr... systems and siRNA design to create new, targeted,...
...2007 - Australian,biotechnology company Avexa (ASX...om its Phase IIb trial for apricitabine (ATC).,ATC... inhibitor,(NRTI) being developed for the treatmen... HIV., The Phase IIb trial compared the effectiven...with drug-resistant HIV with,the effectiveness of ...
Other Medicine Technology:Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 2Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 3Avexa Reports Positive Phase IIb Result 2Avexa Reports Positive Phase IIb Result 3Avexa Reports Positive Phase IIb Result 4